Ira M. Jacobson
NYU Langone Health · 600 works · 41,057 citations · h-index 87
Top works
- Treatment of Chronic Hepatitis C with Recombinant Interferon Alfa
- Boceprevir for Untreated Chronic HCV Genotype 1 Infection
- Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
- A Randomized, Controlled Trial of Interferon Alfa-2b Alone and after Prednisone Withdrawal for the Treatment of Chronic Hepatitis B
- Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
- Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection
- Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection
- Pathological diagnosis of chronic hepatitis C: A multicenter comparative study with chronic hepatitis B
- Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection
- Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
- Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
- Telaprevir for Previously Treated Chronic HCV Infection
- Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial
- Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection
- Interleukin-28B Polymorphism Improves Viral Kinetics and Is the Strongest Pretreatment Predictor of Sustained Virologic Response in Genotype 1 Hepatitis C Virus
- Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study
- Peginterferon alfa-2b and weight-based or flat-dose ribavirin in chronic hepatitis C patients
- A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2008 Update
- Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates
- Retreatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin